MS News (Y!)

Research and Markets has announced the addition of the "PharmaPoint: Multiple Sclerosis - Germany Drug Forecast and

Research and Markets has announced the addition of the "PharmaPoint: Multiple Sclerosis - France Drug Forecast and M

Research and Markets has announced the addition of the "Tysabri - Forecast and Market Anal

Research and Markets has announced the addition of the "PharmaPoint: Multiple Sclerosis - China Drug Forecast and Ma

By Vrinda Manocha (Reuters) - XenoPort Inc said it would stop development of an experimental multiple sclerosis treatment it planned to launch in 2015 after a late-stage trial failed to show significant improvement over a placebo. Shares of the company fell 26 percent to $5.03 in morning trade on the Nasdaq. "This is disappointing, given (the drug's) promising mid-stage data," Wells Fargo ...

The Western Pennsylvania Chapter of the National Multiple Sclerosis Society crossed the finish line of a successful 2013 event season with its Meadville MS Walk in Roche Park on Sunday afternoon, according to organizers and participants.

Research and Markets has announced the addition of the "Gilenya - Forecast and Market Anal

Research and Markets has announced the addition of the "PharmaPoint: Multiple Sclerosis - US Drug Forecast and Marke

Research and Markets has announced the addition of the "PharmaPoint: Multiple Sclerosis - Japan Drug Forecast and Ma

NEW YORK, May 16, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market ...

Research and Markets has announced the addition of the "Laquinimod - Forecast and Market Analysi

Research and Markets has announced the addition of the "Tcelna - Forecast and Market Analys

Research and Markets has announced the addition of the "Avonex - Forecast and Market Analys

Research and Markets has announced the addition of the "BG-12 - Forecast and Market Analysis

Research and Markets has announced the addition of the "Betaseron/Betaferon - Forecast an

Research and Markets has announced the addition of the "Lemtrada - Forecast and Market Analysis to

NEW YORK, May 14, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis ...

NEW YORK, May 14, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis ...

NEW YORK, May 14, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis ...

Research and Markets has announced the addition of the "PharmaPoint: Multiple Sclerosis - Spain Drug Forecast and Ma